Daniel S. Goldman sold Ono Pharmaceutical Co Ltd (PINK: OPHLY)
Daniel S. Goldman (D-NY), a U.S. Representative, has disclosed 1 trade in Ono Pharmaceutical Co Ltd (OPHLY) since 2023, a single sale, worth an estimated $8K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a sale: Daniel S. Goldman sold $1,001 - $15,000 of Ono Pharmaceutical Co Ltd (PINK: OPHLY) on July 10, 2023. Since that trade, OPHLY is down -0.66% against the S&P 500 up +71.78%, an outperformance of -72.44%.
Data updated
Daniel S. Goldman's OPHLY trades vs the price
OPHLY is down -0.66% since Daniel S. Goldman sold on July 10, 2023, versus +71.78% for the S&P 500.
Performance since this trade
All Daniel S. Goldman OPHLY trades
Daniel S. Goldman & OPHLY trading FAQ
Is it legal for Daniel S. Goldman to trade Ono Pharmaceutical Co Ltd (OPHLY) stock?
Yes. Members of Congress are allowed to trade individual stocks, including Ono Pharmaceutical Co Ltd (OPHLY), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did Daniel S. Goldman sell OPHLY?
Daniel S. Goldman disclosed a sale of $1,001 - $15,000 of Ono Pharmaceutical Co Ltd (OPHLY) on July 10, 2023, according to public STOCK Act filings.
How has OPHLY performed since Daniel S. Goldman's trade?
Since Daniel S. Goldman sold OPHLY on July 10, 2023, the stock is down -0.66%, versus +71.78% for the S&P 500 over the same period, an outperformance of -72.44%.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional OPHLY trades?
Quantellect tracks every disclosed congressional trade in Ono Pharmaceutical Co Ltd (OPHLY) on the Ono Pharmaceutical Co Ltd congressional trading page, which aggregates filings across all members of Congress.
Daniel S. Goldman's OPHLY tradesAll congressional filings for Ono Pharmaceutical Co LtdDaniel S. Goldman's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.